<DOC>
	<DOC>NCT01289171</DOC>
	<brief_summary>Many human immunodeficiency virus (HIV)-positive children are afflicted with diffuse flat warts that have been recalcitrant to multiple treatments.The aim of this prospective study was to evaluate the efficacy, safety and tolerability of 15% glycolic acid lotion (NeoStrata) for treatment of flat warts in HIV-positive children in Botswana. Additionally, the investigators characterized the flat warts in this population, including Human Papillomavirus (HPV) type(s) and degree of immunosuppression within the patients.</brief_summary>
	<brief_title>Acquired Epidermodysplasia Verruciformis (EV) Syndrome in HIV-infected Pediatric Patients</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Epidermodysplasia Verruciformis</mesh_term>
	<mesh_term>Warts</mesh_term>
	<mesh_term>Glycolic acid</mesh_term>
	<criteria>Male or female HIVpositive patients 7 years of age or older with at least 15 flat warts, diagnosed clinically by one dermatologist (RLM), on the face and/or dorsal hands were included in the study. Key exclusion criteria included current use of potential wart treatments or other topical OTC products on the affected area(s).</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>The efficacy, tolerability and safety of 15% glycolic acid lotion for treatment of diffuse flat warts among HIV+ children were investigated</keyword>
</DOC>